These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31113488)

  • 1. Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment.
    Relaño-Rodríguez I; Juárez-Sánchez R; Pavicic C; Muñoz E; Muñoz-Fernández MÁ
    J Nanobiotechnology; 2019 May; 17(1):69. PubMed ID: 31113488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Activation of Latent HIV-1 Expression by Novel Histone Deacetylase Inhibitors and Bryostatin-1.
    Martínez-Bonet M; Clemente MI; Serramía MJ; Muñoz E; Moreno S; Muñoz-Fernández MÁ
    Sci Rep; 2015 Nov; 5():16445. PubMed ID: 26563568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anionic Carbosilane Dendrimers Destabilize the GP120-CD4 Complex Blocking HIV-1 Entry and Cell to Cell Fusion.
    Guerrero-Beltran C; Rodriguez-Izquierdo I; Serramia MJ; Araya-Durán I; Márquez-Miranda V; Gomez R; de la Mata FJ; Leal M; González-Nilo F; Muñoz-Fernández MA
    Bioconjug Chem; 2018 May; 29(5):1584-1594. PubMed ID: 29570280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G2-S16 sulfonate dendrimer as new therapy for treatment failure in HIV-1 entry inhibitors.
    Rodríguez-Izquierdo I; Natalia C; García F; Los Ángeles Muñoz-Fernandez M
    Nanomedicine (Lond); 2019 May; 14(9):1095-1107. PubMed ID: 31066644
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action.
    Ceña-Diez R; Vacas-Córdoba E; García-Broncano P; de la Mata FJ; Gómez R; Maly M; Muñoz-Fernández MÁ
    Int J Nanomedicine; 2016; 11():2147-62. PubMed ID: 27274240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral mechanism of polyanionic carbosilane dendrimers against HIV-1.
    Vacas-Córdoba E; Maly M; De la Mata FJ; Gómez R; Pion M; Muñoz-Fernández MÁ
    Int J Nanomedicine; 2016; 11():1281-94. PubMed ID: 27103798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology against human cytomegalovirus in vitro: polyanionic carbosilane dendrimers as antiviral agents.
    Relaño-Rodríguez I; Espinar-Buitrago MS; Martín-Cañadilla V; Gómez-Ramirez R; Jiménez JL; Muñoz-Fernández MA
    J Nanobiotechnology; 2021 Mar; 19(1):65. PubMed ID: 33658029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bryostatin-1 Decreases HIV-1 Infection and Viral Production in Human Primary Macrophages.
    Hany L; Turmel MO; Barat C; Ouellet M; Tremblay MJ
    J Virol; 2022 Feb; 96(4):e0195321. PubMed ID: 34878918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral drugs do not interfere with bryostatin-mediated HIV-1 latency reversal.
    Martínez-Bonet M; Clemente MI; Álvarez S; Díaz L; García-Alonso D; Muñoz E; Moreno S; Muñoz-Fernández MÁ
    Antiviral Res; 2015 Nov; 123():163-71. PubMed ID: 26427554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced activity of carbosilane dendrimers against HIV when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicides.
    Vacas-Córdoba E; Galán M; de la Mata FJ; Gómez R; Pion M; Muñoz-Fernández MÁ
    Int J Nanomedicine; 2014; 9():3591-600. PubMed ID: 25114528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G2-S16 Polyanionic Carbosilane Dendrimer Can Reduce HIV-1 Reservoir Formation by Inhibiting Macrophage Cell to Cell Transmission.
    Relaño-Rodríguez I; Espinar-Buitrago MS; Martín-Cañadilla V; Gómez-Ramírez R; Muñoz-Fernández MÁ
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of carbosilane dendrimers with an antiretroviral combination against HIV-1 in the presence of semen-derived enhancer of viral infection.
    García-Broncano P; Ceña-Diez R; de la Mata FJ; Gómez R; Resino S; Muñoz-Fernández MÁ
    Eur J Pharmacol; 2017 Sep; 811():155-163. PubMed ID: 28577966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activity profile of carbosilane dendrimer G2-STE16 in combination with other dendrimers and antiretrovirals as topical anti-HIV-1 microbicide.
    Sepúlveda-Crespo D; Lorente R; Leal M; Gómez R; De la Mata FJ; Jiménez JL; Muñoz-Fernández MÁ
    Nanomedicine; 2014 Apr; 10(3):609-18. PubMed ID: 24135563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyanionic carbosilane dendrimer-conjugated antiviral drugs as efficient microbicides: Recent trends and developments in HIV treatment/therapy.
    Sepúlveda-Crespo D; Gómez R; De La Mata FJ; Jiménez JL; Muñoz-Fernández MÁ
    Nanomedicine; 2015 Aug; 11(6):1481-98. PubMed ID: 25835558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of G2-S16 dendrimer/dapivirine antiretroviral as a new HIV-1 microbicide.
    Guerrero-Beltrán C; Prieto A; Leal M; Jiménez JL; Muñoz-Fernández MÁ
    Future Med Chem; 2019 Dec; 11(23):3005-3013. PubMed ID: 31710246
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicides.
    Briz V; Sepúlveda-Crespo D; Diniz AR; Borrego P; Rodes B; de la Mata FJ; Gómez R; Taveira N; Muñoz-Fernández MÁ
    Nanoscale; 2015 Sep; 7(35):14669-83. PubMed ID: 26274532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.
    Bullen CK; Laird GM; Durand CM; Siliciano JD; Siliciano RF
    Nat Med; 2014 Apr; 20(4):425-9. PubMed ID: 24658076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of sulphated and naphthylsulphonated carbosilane dendrimers as topical microbicides to prevent HIV-1 sexual transmission.
    Vacas Córdoba E; Arnaiz E; Relloso M; Sánchez-Torres C; García F; Pérez-Álvarez L; Gómez R; de la Mata FJ; Pion M; Muñoz-Fernández MÁ
    AIDS; 2013 May; 27(8):1219-29. PubMed ID: 23925376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of Nanotechnology to Fight HIV Sexual Transmission: The Trip of G2-S16 Polyanionic Carbosilane Dendrimer to Possible Pre-Clinical Trials.
    Relaño-Rodríguez I; Muñoz-Fernández MÁ
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations.
    Grau-Expósito J; Luque-Ballesteros L; Navarro J; Curran A; Burgos J; Ribera E; Torrella A; Planas B; Badía R; Martin-Castillo M; Fernández-Sojo J; Genescà M; Falcó V; Buzon MJ
    PLoS Pathog; 2019 Aug; 15(8):e1007991. PubMed ID: 31425551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.